Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

57
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
57
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Urologic Endoscopic Procedure: Cystoscopic Examination01:28

Urologic Endoscopic Procedure: Cystoscopic Examination

60
Meaning of Cystoscopic Examination:Cystoscopy is an essential diagnostic tool in urology that is used to assess the structure and function of the genitourinary system. It provides a direct view of the urethra, bladder, and, in some cases, the ureteral openings. This procedure helps detect structural abnormalities, infections, cancers, and blockages in the urinary tract. There are two types of cystoscopy:Flexible cystoscopy is commonly performed in outpatient settings due to its less invasive...
60
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

83
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDO1 is a new biomarker to discriminate aggressive forms of prostate cancer.

Oncogene·2026
Same author

Robot-assisted versus open surgery for multiple ipsilateral renal tumors: a multicenter matched cohort study (UroCCR-60).

Journal of robotic surgery·2026
Same author

Patient-reported outcomes and experiences in outpatient vs inpatient robot-assisted radical prostatectomy: the BETTY trial.

BJU international·2026
Same author

Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.

European urology oncology·2026
Same author

Digital Systematic Collection of Data for Patient-reported Outcome and Experience Measures Reveals Real-world Recovery Trajectories After Robot-assisted Radical Prostatectomy.

European urology focus·2025
Same author

Impact of intra-abdominal pressure with AirSeal<sup>®</sup> system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomy.

World journal of urology·2025
Same journal

Editorial Commentary.

Urology practice·2026
Same journal

Reply by authors.

Urology practice·2026
Same journal

The Impact of Patient-Provider Relationships on Prostate Cancer Screening: A Cross-Sectional Analysis of the All of Us Research Program.

Urology practice·2026
Same journal

Adjuvant Radiation Therapy Versus Initial Observation for Patients After Prostatectomy with Adverse Pathology: Have Findings from 3 Randomized Clinical Trials Influenced Clinical Practice?

Urology practice·2026
Same journal

National Patterns and Predictors of Perioperative Intravesical Chemotherapy Use Following Nephroureterectomy for Upper Tract Urothelial Carcinoma.

Urology practice·2026
Same journal

Patient Trust and Medical Mistrust Toward Overactive Bladder Therapies: General Consumer Awareness and Perceptions.

Urology practice·2026
See all related articles

Related Experiment Video

Updated: Jul 20, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

278

Does PCA3 Really Help Urologists?

Guillaume Ploussard1, Alexandre de la Taille1

  • 1Centre Hospitalier Universitaire Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris and Hôpital Henri Mondor (AdlT), Assistance Publique Hôpitaux de Paris, Créteil, France.

Urology Practice
|August 4, 2023
PubMed
Summary
This summary is machine-generated.

The PCA3 score shows higher specificity than PSA for diagnosing prostate cancer, potentially reducing unnecessary biopsies. Further research is needed to confirm improved health outcomes and cost-effectiveness.

Keywords:
biological markersbiopsyhumanprostateprostate cancer antigen 3prostatic neoplasms

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

456
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.2K

Related Experiment Videos

Last Updated: Jul 20, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

278
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

456
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

1.2K

Area of Science:

  • Urology
  • Oncology
  • Diagnostic Biomarkers

Background:

  • Prostate cancer diagnosis relies on PSA, but its specificity is limited.
  • The PCA3 score has emerged as a promising biomarker for prostate cancer detection.

Purpose of the Study:

  • To review the diagnostic and prognostic roles of PCA3.
  • To highlight limitations and perspectives on PCA3's clinical usefulness.

Main Methods:

  • Literature review of MEDLINE, Scopus, and Web of Science databases.
  • Focused on three patient populations: initial biopsy, rebiopsy, and men with prostate cancer.

Main Results:

  • PCA3 score demonstrates superior specificity and predictive values compared to PSA, with slightly lower sensitivity.
  • PCA3 aids diagnostic algorithms before biopsy; optimal cutoffs are suggested for initial (25) and repeat (35) biopsies.
  • PCA3 correlates with cancer significance, indicating potential roles in detecting insignificant cancer and guiding active surveillance.

Conclusions:

  • PCA3 shows potential benefit before repeat biopsies, especially with low scores, as the risk of undetected significant cancer is low.
  • While PCA3 may reduce unnecessary biopsies, its cost-benefit requires further assessment based on health outcomes.